I guess Hipity and mbacsun don't understand what 8% Institutional holdings mean. This stock hasn't even begun to rise...2013=400%+ gains...Dr. Kim says 2014 will DWARF 2013..so you're saying $10(which is SMALLER gains than 2013) is dwarfing?? Your math is a bit shady I think.
I'm more than happy to be wrong on this one as I own quite a few shares. I just think that a 2 billion dollar market cap at $10 is sufficient for a company with one successful phase 2 trial in a yet untested immunotherapy space. There's not a lot of precedent in biotech where a company has a 2 billion dollar market cap pre-phase 3. I do trust Kim, but it's unclear whether he's referring to percentage gain. If INO gets to $10, that's approximately a 1.4 billion dollar increase in market cap compared to approximately 400 million dollar increase we saw in 2013. I see that as sufficiently dwarfing.
I'm confident that INO will get there eventually and it makes little difference whether it is in 2014 or later. Planning to hold my shares tight until INO gives me a reason not to.
That 2014 will dwarf 2013 can be as his statement addressed to the longs who bought shares below $2 or even $1. If so, $10 would mean 500%+ gain. We are just trying to be reasonable here. If everything you can predict is just literally based on Dr. Kim's saying and extrapolate that on the current share price to justify $18 share price prediction. I think it's too way off base.
Too much. $6 is more reasonable. $10 is the absolute max if all the stars align and we we see multiple partnerships and breakthrough designation or fast track status. Wouldn't hold my breath for $10, though.
You've got to be joking right? I bet when someone said $3 EOY 2013 you prob said the same stupid comment then too. I estimate between $15-20 with good VGX-3100 data and partnership(probably multiple), then start to price in other 11~ candidates, milestones, royalties, plus patents, funding etc..
My bad. meant to say 30 cents / week is doable with good news, also, recall most large institutions will pile in after we reach $5/ share. That is also the price at which they can recommend to their clients.